Tofacitinib Treatment for Pretibial Myxedema

JAMA Dermatol. 2024 May 1;160(5):578-580. doi: 10.1001/jamadermatol.2024.0344.
No abstract available

Plain language summary

This case report describes tofacitinib treatment for 2 patients with pretibial myxedema.

Publication types

  • Case Reports

MeSH terms

  • Humans
  • Leg Dermatoses / diagnosis
  • Leg Dermatoses / drug therapy
  • Leg Dermatoses / pathology
  • Myxedema* / diagnosis
  • Myxedema* / drug therapy
  • Piperidines* / administration & dosage
  • Piperidines* / therapeutic use
  • Protein Kinase Inhibitors / administration & dosage
  • Protein Kinase Inhibitors / therapeutic use
  • Pyrimidines* / administration & dosage
  • Pyrimidines* / therapeutic use
  • Pyrroles / administration & dosage
  • Pyrroles / therapeutic use
  • Treatment Outcome

Substances

  • Piperidines
  • Protein Kinase Inhibitors
  • Pyrimidines
  • Pyrroles